TIDMFDBK
Feedback PLC
29 September 2021
Feedback plc
RNS REACH
Feedback appointed to national NHS AI procurement framework
-- The national framework addresses the Provision of Artificial
Intelligence (A.I), Imaging and Radiotherapy Equipment, Associated
Products and Diagnostic Imaging to public and private sector
organisations
-- Bleepa has been awarded onto the framework as a product which
can facilitate the deployment of AI imaging tools into frontline
clinical settings through mobile devices, enabling on-the-go access
to AI
-- The framework's estimated overall value of up to GBP360m
enables any NHS body a route to procure the Bleepa AI solution for
the purpose of developing, evaluating or clinically delivering AI
imaging tools
London, 29 September 2021 : Feedback plc (AIM: FDBK, "Feedback"
or the "Company"), the specialist clinical communication company,
announces that it has been awarded a place on a national
procurement framework: The Provision Artificial Intelligence (A.I),
Imaging and Radiotherapy Equipment, Associated Products and
Diagnostic Imaging.
The Company has developed an AI module for the Bleepa
communication platform that enables third party AI tools to be
deployed within the app by frontline clinical users in order to
assist with the diagnostic interpretation of medical imaging
studies such as X-rays, CT scans and MRIs. The AI module has
already been configured to deploy the AI tools of our commercial
partners Qure.ai and Axial 3D.
The Bleepa AI module will allow NHS Bleepa customers to engage
with AI tools of their choosing, knowing that they have a secure
route of deployment right into the hands of their clinicians.
Bleepa's availability as a mobile platform allows these AI tools to
be deployed in any connected setting realising the full benefits of
AI driven point-of-care diagnostics in more places and in a way
that can't be recognised through traditional PACS based deployment,
that is largely confined to desktop PCs within hospitals.
Enabling on-the-go access to the latest AI diagnostic support
tools is the next evolution in the Company's mission to enable
clinicians to make better decisions faster from any location. The
framework will allow NHS organisations to buy the Bleepa AI
solution as a platform for AI tool deployment, allowing them to
meaningfully engage with any number of AI tools knowing that there
is one common route for deployment into their clinical setting. The
Company will additionally charge the AI companies a deployment fee
through the platform.
The framework is run by Shared Business Services (SBS) on behalf
of NHS organisations and enables NHS customers to directly procure
equipment related to AI imaging, including Bleepa's AI module. The
framework has an estimated overall value of up to GBP360m which
lasts until 02/05/2025 and will be a key resource to enable the NHS
to engage with AI technology. Details of the framework can be found
at:
https://uk.eu-supply.com/ctm/Supplier/PublicTenders/ViewNotice/27445
SBS describe the framework: " This is a framework agreement for
the supply of Artificial Intelligence software and platforms and
also for the supply of Medical Imaging and Radiotherapy equipment,
associated products and Diagnostic Imaging equipment. The framework
aims to provide a simple, effective, efficient and compliant route
to market for the purchase/supply of a broad range of medical
imaging and radiology products and services, including related
artificial intelligence solutions. This will be for use by both NHS
Customers (and other public & private sector organisations)
through means of either direct call-off or further competition if
required."
Dr Tom Oakley, CEO of Feedback, said: "This national framework
is recognition of the increasing interest in AI technology across
the NHS and will enable NHS customers to directly procure the
Bleepa AI module as a vehicle for delivering the ever-growing array
of AI imaging tools available. Clinicians do not want multiple apps
on their devices and there is a clear role for a single platform
that facilitates the deployment of multiple AI tools. As a mobile
first solution, that additionally facilitates patient pathways and
clinical case discussion, Bleepa is the perfect deployment platform
for AI tools, we can put the latest AI technology literally into
the hands of clinicians, through their own devices, in any internet
connected location, allowing truly on-the-go access to the best
available diagnostic support tools and point-of-care deployment of
AI technology in even more care settings."
-Ends-
Enquiries:
Feedback plc +44 (0)1954 718072
Tom Oakley, CEO IR@fbk.com
Lindsay Melvin, CFO
Panmure Gordon (UK) Limited (NOMAD
and Broker)
Emma Earl/Freddy Crossley (Corporate
Finance)
Rupert Dearden (Corporate Broking) +44 (0)20 7886 2500
Walbrook PR Ltd Tel: 020 7933 8780 or feedbackplc@walbrookpr.com
Paul McManus/Nick Rome/Nicholas Johnson 07980 541 893 or 07748 325 236
or 07884 664 686
Notes to Editors
Feedback plc (AIM: FDBK) is a pioneer of regulated clinical
communication products. Its core product, Bleepa, is a
revolutionary medical imaging communications app, providing an
easy-to-use, high quality tool to enable remote and secure
communications between front-line clinicians and teams.
Importantly, it is the only CE marked medical imaging
communications platform on the NHSx clinical communications tools
framework. Bleepa has unparalleled functionality for everyday
practice and can be accessed from any internet-connected device,
enabling control of patient cases when on the go.
Its highly scalable Software as a Service ("SaaS") based revenue
model will provide increasing levels of visibility as the Company
grows its customer base. With a growing distribution base and
technology in place, the focus is on leveraging key relationships
in order to drive sales both in the UK and internationally to all
forms of care providers. As a fully certified medical device,
Bleepa aims to disrupt the medical imaging communications market
and, importantly, increase the accuracy and speed of clinical
review.
About NHS Shared Business Services
Established in 2005 by the Department of Health and Social Care
(DHSC) in a partnership with digital experts Sopra Steria , its
services are aimed at increasing efficiency and quality, saving
time and money, and supporting patient care. The DHSC is
transforming its current multiple delivery pathways into one
intelligent, interconnected ecosystem that meets the ever-changing
needs of the NHS in the digital world. Offering a seamless
experience with a single sign-on, its modular solutions are aimed
at enabling NHS organisations and suppliers to access the services
they need, when they need them including access to suppliers or
tendering for a multi-million pound project.
https://www.sbs.nhs.uk
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
Reach is a non-regulatory news service. By using this service an
issuer is confirming that the information contained within this
announcement is of a non-regulatory nature. Reach announcements are
identified with an orange label and the word "Reach" in the source
column of the News Explorer pages of London Stock Exchange's
website so that they are distinguished from the RNS UK regulatory
service. Other vendors subscribing for Reach press releases may use
a different method to distinguish Reach announcements from UK
regulatory news.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRAEVLFLFKLZBBZ
(END) Dow Jones Newswires
September 29, 2021 02:00 ET (06:00 GMT)
Feedback (LSE:FDBK)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Feedback (LSE:FDBK)
Historical Stock Chart
Von Jul 2023 bis Jul 2024